StonvexLoading…
StonvexStonvexStonvexCore line items from SLP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $42.71M | $18.42M | $79.18M | $61.72M |
Operating Income | $6.34M | $713.00K | $-70.73M | $-71.39M |
Net Income | $5.21M | $676.00K | $-64.72M | $-64.04M |
EPS (Diluted) | $0.26 | $0.03 | $-3.22 | $-3.19 |
Total Assets | $146.48M | $137.83M | $131.94M | $134.36M |
Total Liabilities | $12.71M | $10.72M | $7.13M | $10.58M |
Cash & Equivalents | $25.73M | $30.19M | $30.85M | $26.95M |
Free Cash Flow OCF − CapEx | $10.60M | $4.23M | $17.41M | $12.09M |
Shares Outstanding | 20.21M | 20.15M | 20.14M | 20.12M |